
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.680 | 2.680 | 0.000 |
Shares | 97.320 | 97.320 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.158 | 17.149 |
Price to Book | 3.718 | 3.717 |
Price to Sales | 5.527 | 5.028 |
Price to Cash Flow | 14.742 | 14.632 |
Dividend Yield | 0.572 | 0.520 |
5 Years Earnings Growth | 6.570 | 8.646 |
Number of long holdings: 83
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 6.91 | 462.13 | +1.15% | |
Amgen | US0311621009 | 6.10 | 296.88 | +0.60% | |
Gilead | US3755581036 | 5.97 | 113.18 | +0.79% | |
Regeneron Pharma | US75886F1075 | 4.90 | 558.87 | +2.46% | |
Alnylam | US02043Q1076 | 4.72 | 401.80 | +2.44% | |
BioNTech | US09075V1026 | 3.03 | 107.34 | -0.15% | |
BeOne Medicines DRC | US07725L1026 | 2.84 | 299.01 | -0.70% | |
Insmed | US4576693075 | 2.64 | 108.69 | +1.31% | |
Ascendis Pharma AS | US04351P1012 | 2.60 | 174.48 | +0.56% | |
Biomarin Pharma | US09061G1013 | 2.54 | 58.14 | +0.50% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cleome Index USA Equities I USD Acu | 3.12B | 0.20 | 13.55 | - | ||
Cleome Index USA Eq C USD Inc | 3.12B | -0.12 | 12.63 | - | ||
Cleome Index USA Eq C USD Acc | 3.12B | -0.12 | 12.63 | 10.91 | ||
Cleome Index USA Equities Z USD Acc | 3.12B | 0.25 | 13.69 | 12.09 | ||
LU1864481541 | 1.42B | -4.08 | -0.49 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review